Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Blood|April 19, 2012
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantationAjay K Gopal, Radhakrishnan Ramchandren, Owen A O'Connor, et al.
Blood|December 24, 2014
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphomaAjay K Gopal, Robert Chen, Scott E Smith, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 24, 2016
Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantationAndrew J Cowan, Zandra K Klippel, Philip A Stevenson, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular LymphomaChaitra Ujjani, Hongkun Wang, Catherine Broome, et al.
British Journal of Haematology|April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Blood Neoplasia|June 19, 2026
Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphomaLorenzo Iovino, Ningxin Ma, Mohamed A Kharfan-Dabaja, et al.
British Journal of Haematology|October 10, 2025
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphomaRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Molecular Cancer Therapeutics|July 3, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell LymphomasJohnnie J Orozco, Manuela C Matesan, Sally J Lundberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Pageof 19